Basic Tool Has Copious Uses in Development of Vaccines and Protein Therapeutics Epitope mapping, initially a basic-science tool for understanding the 3-D interactions between antigens and antibodies, ...

AUSTIN, Texas--(BUSINESS WIRE)-- ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ:IPA) a leader in AI-driven biotherapeutics, is pleased to announce today new benchmarking results that validate the ...

Vaccines have arguably saved more lives than any other medical breakthrough. However, despite the long list of diseases that can now be controlled by vaccination, there are still some urgent unmet ...

New benchmark confirms LENSai’s ability to accurately predict binding on 17 previously unseen antibody-antigen complexes, achieving near-crystallography precision without prior training data.

ROSEMONT, Ill.--(BUSINESS WIRE)--Proteintech, a global leader in antibodies and life science solutions, is excited to announce additional product characterization for primary antibody targets on its ...

Antibodies are a major component of adaptive immunity against invading pathogens. In this presentation, we will describe an analytical approach to characterize the antigen-specific antibody repertoire ...

Proteintech, a global leader in antibodies and life science solutions, today announced the launch of Able AI, a first-of-its-kind artificial intelligence tool that is now available on ptglab.com .

A new microchip invented by Scripps Research scientists can reveal how a person's antibodies interact with viruses—using just a drop of blood. The technology offers researchers faster, clearer ...

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) is one of the best hot stocks to buy according to Wall Street analysts. On July 3, ImmunoPrecise Antibodies announced significant validation for its ...

Epitope mapping is a cornerstone of antibody development, informing everything from IP strategy to candidate selection. Traditionally, this requires expensive, time-consuming lab work using scarce ...